Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Caleres stock
Own Caleres stock in just a few minutes.
Caleres, Inc is a footwear & accessories business based in the US. Caleres shares (CAL) are listed on the NYSE and all prices are listed in US Dollars. Caleres employs 4,900 staff and has a trailing 12-month revenue of around USD$2.1 billion.
How to buy shares in Caleres
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for Caleres. Find the stock by name or ticker symbol: CAL. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Caleres reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Caleres, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Caleres. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
Caleres share price
Use our graph to track the performance of CAL stocks over time.Caleres shares at a glance
Information last updated 2021-04-08.
| 52-week range | USD$4.8204 - USD$22.56 |
|---|---|
| 50-day moving average | USD$18.3674 |
| 200-day moving average | USD$13.9521 |
| Wall St. target price | USD$25 |
| PE ratio | 6.6601 |
| Dividend yield | USD$0.28 (1.34%) |
| Earnings per share (TTM) | USD$1.529 |
Buy Caleres shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Caleres stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Is Caleres under- or over-valued?
Valuing Caleres stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Caleres's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Caleres's P/E ratio
Caleres's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, Caleres shares trade at around 7x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Caleres's PEG ratio
Caleres's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.74. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Caleres's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Caleres's EBITDA
Caleres's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$15.4 million.
The EBITDA is a measure of a Caleres's overall financial performance and is widely used to measure a its profitability.
Caleres financials
| Revenue TTM | USD$2.1 billion |
|---|---|
| Gross profit TTM | USD$824.4 million |
| Return on assets TTM | -1.14% |
| Return on equity TTM | -102.93% |
| Profit margin | -20.74% |
| Book value | $5.274 |
| Market capitalisation | USD$786.7 million |
TTM: trailing 12 months
Shorting Caleres shares
There are currently 1.7 million Caleres shares held short by investors – that's known as Caleres's "short interest". This figure is 6.5% down from 1.9 million last month.
There are a few different ways that this level of interest in shorting Caleres shares can be evaluated.
Caleres's "short interest ratio" (SIR)
Caleres's "short interest ratio" (SIR) is the quantity of Caleres shares currently shorted divided by the average quantity of Caleres shares traded daily (recently around 352936.96969697). Caleres's SIR currently stands at 4.95. In other words for every 100,000 Caleres shares traded daily on the market, roughly 4950 shares are currently held short.
However Caleres's short interest can also be evaluated against the total number of Caleres shares, or, against the total number of tradable Caleres shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Caleres's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Caleres shares in existence, roughly 50 shares are currently held short) or 0.0688% of the tradable shares (for every 100,000 tradable Caleres shares, roughly 69 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Caleres.
Find out more about how you can short Caleres stock.
Caleres share dividends
We're not expecting Caleres to pay a dividend over the next 12 months.
Have Caleres's shares ever split?
Caleres's shares were split on a 3:2 basis on 2 April 2007. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Caleres shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Caleres shares which in turn could have impacted Caleres's share price.
Caleres share price volatility
Over the last 12 months, Caleres's shares have ranged in value from as little as $4.8204 up to $22.56. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Caleres's is 2.7226. This would suggest that Caleres's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Caleres overview
Caleres, Inc. engages in the retail and wholesale of footwear in the United States, China, Canada, China, and Guam. It operates through Famous Footwear and Brand Portfolio segments. The company offers licensed, branded, and private-label athletic, casual, and dress footwear products to women, men, and children. Its retail shoe stores provide brand name athletic, casual, and dress shoes, including Nike, Skechers, adidas, Vans, Converse, Crocs, Puma, Birkenstock, Asics, New Balance, Under Armour, Bearpaw, Timberland, and Sperry, as well as company-owned and licensed brands, such as Dr. Scholl's Shoes, Blowfish Malibu, LifeStride, Naturalizer, Circus by Sam Edelman, Franco Sarto, and Ryka. The company also operates naturalizer.com, naturalizer.ca, vionicshoes.com, samedelman.com, allenedmonds.com, drschollsshoes.com, lifestride.com, francosarto.com, ryka.com, bzees.com, and zodiacshoes.com, as well as Vince.com, blowfishshoes.com, and veronicabeard.com websites. In addition, it designs, sources, and markets footwear to retail stores, such as national chains, online retailers, department stores, mass merchandisers, independent retailers, and catalogs. Further, the company wholesales men's apparel, leather goods, and accessories under the Allen Edmonds brand; Italian footwear Franco Sarto brand; women's shoe collection under the Vince brand; athletic footwear for women under the Rykä brand; and women's footwear under the Bzees brand, as well as Via Spiga brand. It operates approximately 1,086 retail stores. The company was formerly known as Brown Shoe Company, Inc. and changed its name to Caleres, Inc. in May 2015. Caleres, Inc. was founded in 1878 and is headquartered in St. Louis, Missouri.
Frequently asked questions
More guides on Finder
-
How to buy Sigma Labs stock
Steps to owning and managing SGLB, with 24-hour and historical pricing before you buy.
-
How to buy Simpson Manufacturing CoInc stock
Steps to owning and managing SSD, with 24-hour and historical pricing before you buy.
-
How to buy Sequans Communications S-A stock
Steps to owning and managing SQNS, with 24-hour and historical pricing before you buy.
-
How to buy SFL Corporation stock
Steps to owning and managing SFL, with 24-hour and historical pricing before you buy.
-
How to buy Senmiao Technology stock
Steps to owning and managing AIHS, with 24-hour and historical pricing before you buy.
-
How to buy Sensata Technologies Holding stock
Steps to owning and managing ST, with 24-hour and historical pricing before you buy.
-
How to buy Select Bancorp stock
Steps to owning and managing SLCT, with 24-hour and historical pricing before you buy.
-
How to buy Second Sight Medical Products stock
Steps to owning and managing EYES, with 24-hour and historical pricing before you buy.
-
How to buy Sibanye Stillwater stock
Steps to owning and managing SBSW, with 24-hour and historical pricing before you buy.
-
How to buy Shinhan Financial Group CoLtd stock
Steps to owning and managing SHG, with 24-hour and historical pricing before you buy.
Ask an Expert